LENZ Therapeutics (LENZ) Institutional Ownership $27.93 +0.97 (+3.60%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for LENZ Therapeutics (NASDAQ:LENZ)CurrentInstitutional OwnershipPercentage54.32%Number ofInstitutional Buyers(last 12 months)19TotalInstitutional Inflows(last 12 months)$109.57MNumber ofInstitutional Sellers(last 12 months)0 Get LENZ Insider Trade Alerts Want to know when executives and insiders are buying or selling LENZ Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LENZ Institutional Buying and Selling by Quarter Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here LENZ Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/3/2024 SG Americas Securities LLC4,523$107K0.0%N/A0.124% 8/15/2024Deerfield Management Company L.P. Series C17,353$300K0.0%N/A0.476% 8/14/2024Squarepoint Ops LLC10,477$181K0.0%N/A0.287% 8/14/2024Marshall Wace LLP22,554$390K0.0%N/A0.618% 8/9/2024Renaissance Technologies LLC60,166$1.04M0.0%+28.4%1.649% 8/9/2024Dimensional Fund Advisors LP37,190$644K0.0%+58.0%1.019% 8/5/2024BBR Partners LLC20,000$346K0.0%N/A0.548% 8/1/2024Rhumbline Advisers16,812$291K0.0%+265.6%0.461% 7/26/2024Bank of New York Mellon Corp39,737$687K0.0%+255.4%1.089% 7/16/2024 Wealth Enhancement Advisory Services LLC83,103$1.44M0.0%N/A2.277% 5/17/2024RA Capital Management L.P.4,178,823$93.31M1.2%N/A114.488% 5/17/2024Ikarian Capital LLC85,000$1.90M0.2%N/A2.329% 5/16/2024Jacobs Levy Equity Management Inc.37,176$830K0.0%N/A1.019% 5/14/2024American International Group Inc.1,973$44K0.0%N/A0.054% 5/10/2024Vanguard Group Inc.206,952$4.62M0.0%N/A5.670% 5/7/2024 Marquette Asset Management LLC5,865$131K0.0%N/A0.161% 5/2/2024Jennison Associates LLC134,740$3.01M0.0%N/A3.692% 5/1/2024BNP Paribas Financial Markets16,221$362K0.0%N/A0.444% 4/25/2024BML Capital Management LLC63,916$1.43M0.9%N/A1.751% (Data available from 1/1/2016 forward) LENZ Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LENZ shares? During the previous two years, 19 institutional investors and hedge funds held shares of LENZ Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($93.31M), Vanguard Group Inc. ($4.62M), Jennison Associates LLC ($3.01M), Ikarian Capital LLC ($1.90M), Wealth Enhancement Advisory Services LLC ($1.44M), BML Capital Management LLC ($1.43M), and Renaissance Technologies LLC ($1.04M).Learn more on LENZ's institutional investors. What percentage of LENZ Therapeutics stock is owned by institutional investors? 54.32% of LENZ Therapeutics stock is owned by institutional investors. Learn more on LENZ's institutional investor holdings. Which institutional investors have been buying LENZ Therapeutics stock? Of the 19 institutional investors that purchased LENZ Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($4.18M), Vanguard Group Inc. ($206.95K), Jennison Associates LLC ($134.74K), Ikarian Capital LLC ($85K), Wealth Enhancement Advisory Services LLC ($83.10K), BML Capital Management LLC ($63.92K), and Jacobs Levy Equity Management Inc. ($37.18K). How much institutional buying is happening at LENZ Therapeutics? Institutional investors have bought a total of 4,956,399 shares in the last 24 months. This purchase volume represents approximately $109.57M in transactions. Related Companies KYMR Institutional Ownership APGE Institutional Ownership TWST Institutional Ownership CGON Institutional Ownership SRRK Institutional Ownership SWTX Institutional Ownership VCEL Institutional Ownership BEAM Institutional Ownership TARS Institutional Ownership RXRX Institutional Ownership This page (NASDAQ:LENZ) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENZ Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENZ Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
